Gyre Therapeutics, Inc. (GYRE)
NASDAQ·Healthcare·Biotechnology
$7.70
+0.85%
Mkt Cap $679.38M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$16.00
Range $16.00 – $16.00
Implied Upside
+107.9%
Consensus $16.00 vs current $7.70
NASDAQ·Healthcare·Biotechnology
$7.70
+0.85%
Mkt Cap $679.38M
No recent rating data.
Price Target (2 analysts)
$16.00
Range $16.00 – $16.00
+107.9%
Consensus $16.00 vs current $7.70